taurocholic acid has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbas, C; Berenguer, J; Brochado-Kith, O; Díez, C; Fernández-Rodríguez, A; González-García, J; Hontañon, V; Jiménez-Sousa, MA; Martínez, I; Micán, R; Pérez-Latorre, L; Resino, S; Rojo, D; Virseda-Berdices, A | 1 |
| Bridges, AS; Brouwer, KL; Corbett, AH; Kashuba, AD; McRae, M; Rezk, NL; Tien, HC | 1 |
2 other study(ies) available for taurocholic acid and HIV Coinfection
| Article | Year |
|---|---|
Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients.
Topics: Antiviral Agents; Biomarkers; Female; Hepatitis C; HIV Infections; Humans; Inflammation; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Phosphatidylcholines; Severity of Illness Index; Spain; Taurocholic Acid | 2022 |
Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity.
Topics: Adult; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Chromatography, High Pressure Liquid; Early Diagnosis; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lithocholic Acid; Liver; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Tandem Mass Spectrometry; Taurocholic Acid; Time Factors | 2010 |